Table 2.
Correlation between miR-194-5p expression and clinicopathologic chacteristics in 60 CCA patients
| Variabls | miR-194-5p expression | ||
|---|---|---|---|
| Low(n = 45) | High(n = 15) | P value | |
| n(%) | n(%) | ||
| Age (years) | |||
| > 60 | 28(62.22%) | 10(66.67%) | 0.7571 |
| ≤ 60 | 17(37.78%) | 5(33.33%) | |
| Gender | |||
| Male | 25(55.56%) | 7(46.67%) | 0.5501 |
| Female | 20(44.44%) | 8(53.33%) | |
| Histological differentiation | |||
| Well | 12(26.67%) | 6(40.00%) | 0.2940 |
| Moderate | 14(31.11%) | 6(40.00%) | |
| Poor | 19(42.22%) | 3(20.00%) | |
| TNM stage | |||
| I-II | 18(40.00%) | 12(80.00%) | 0.0073 |
| III-IV | 27(60.00%) | 3(20.00%) | |
| CA19–9 (U/ml) | |||
| ≤ 37 | 11(24.44%) | 7(46.67%) | 0.1038 |
| > 37 | 34(75.56%) | 8(53.33%) | |
| Lymph node metastasis | |||
| No | 20(44.44%) | 13(86.67%) | 0.0044 |
| Yes | 25(55.56%) | 2(13.33%) | |
| Distant metastasis | |||
| No | 32(71.11%) | 14(93.33%) | 0.0780 |
| Yes | 13(28.89%) | 1(6.67%) | |
Boldface indicates statistically significant values (P < 0.05)